Published in Cardiol J on January 01, 2009
Atrial fibrillation (acute onset). BMJ Clin Evid (2011) 0.79
Quinidine, but not eicosanoid antagonists or dexamethasone, protect the gut from platelet activating factor-induced vasoconstriction, edema and paralysis. PLoS One (2015) 0.75
Is newer better? Propafenone versus quinidine for conversion of atrial fibrillation. Cardiol J (2009) 0.75
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med (2015) 6.00
Heat effects on mortality in 15 European cities. Epidemiology (2008) 4.63
The temporal pattern of mortality responses to air pollution: a multicity assessment of mortality displacement. Epidemiology (2002) 3.21
Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J (2009) 2.68
[Apical ballooning syndrome in a 57-year-old woman during premedication for general anaesthesia]. Kardiol Pol (2006) 2.67
Resistance to oral antiplatelet drugs--a Position Paper of the Working Group on antiplatelet drug resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society. Kardiol Pol (2008) 2.63
The temporal pattern of respiratory and heart disease mortality in response to air pollution. Environ Health Perspect (2003) 2.22
Regional differences in determining cardiovascular diseases as the cause of death in Poland: time for change. Kardiol Pol (2012) 2.06
OSACS score-a new simple tool for identifying high risk for Obstructive Sleep Apnea Syndrome based on clinical parameters. Anatol J Cardiol (2014) 1.99
Clinical, biochemical and genetical resistance to clopidogrel in a patient with the recurrent coronary stent thrombosis--a case report and review of the literature. Int J Cardiol (2005) 1.95
Efficacy of multi-electrode duty-cycled radiofrequency ablation in patients with paroxysmal and persistent atrial fibrillation. Cardiol J (2013) 1.93
The role of cardiac registries in evidence-based medicine. Eur Heart J (2010) 1.83
Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol (2005) 1.71
Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension. Chest (2007) 1.66
Pertussis in Poland. Int J Epidemiol (2004) 1.64
Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum. J Clin Lipidol (2013) 1.58
Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial. Eur Heart J (2004) 1.58
Influence of C3435T multidrug resistance gene-1 (MDR-1) polymorphism on platelet reactivity and prognosis in patients with acute coronary syndromes. Kardiol Pol (2009) 1.54
Leptin in acute myocardial infarction and period of convalescence in patients with type 2 diabetes mellitus. Kardiol Pol (2010) 1.47
Cognitive disorders in elderly patients with permanent atrial fibrillation. Kardiol Pol (2009) 1.46
Availability of automated external defibrillators in the city of Warsaw - status for May 2009. Kardiol Pol (2010) 1.45
Plasma adiponectin levels in acute myocardial infarction and during the postinfarction recovery period in patients with type 2 diabetes mellitus. Kardiol Pol (2011) 1.44
Efficacy of catheter ablation in patients with an electrical storm. Kardiol Pol (2011) 1.43
Comparison of on-admission ST-segment elevation tako-tsubo patients and myocardial infarction women: in-hospital course and long-term follow-up. Kardiol Pol (2012) 1.43
The effects of left ventricular diastolic function on natriuretic peptide levels after cardioversion of atrial fibrillation. Kardiol Pol (2009) 1.42
What has changed in the treatment of ST-segment elevation myocardial infarction in Poland in 2003-2009? Data from the Polish Registry of Acute Coronary Syndromes (PL-ACS). Kardiol Pol (2011) 1.42
CHA2DS2-VASc and R2CHA2DS2-VASc scores have predictive value in patients with acute coronary syndromes. Pol Arch Med Wewn (2015) 1.41
IgG, IgM and inflammatory markers serum concentration in patients with acute coronary syndrome: a pilot study. Kardiol Pol (2012) 1.41
Influence of different antiplatelet treatment regimens for primary percutaneous coronary intervention on all-cause mortality. Eur Heart J (2009) 1.41
Access to selected diagnostic procedures in the management of heart failure patients in Poland - POLKARD 2005. Kardiol Pol (2010) 1.41
No correlation between atrial natriuretic peptide concentrations and echocardiographic measurements of left atrial size or left ventricular size and function in patients with persistent atrial fibrillation. Pacing Clin Electrophysiol (2005) 1.41
Abrasions of the outer silicone insulation of endocardial leads in their intracardiac part: a new mechanism of lead-dependent endocarditis. Europace (2012) 1.40
Atrial natriuretic peptide level after cardioversion of chronic atrial fibrillation. Int J Cardiol (2002) 1.40
Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation. Kardiol Pol (2009) 1.39
Osborn waves during therapeutic hypothermia in a young ST-ACS patient after out-of-hospital cardiac arrest. Kardiol Pol (2013) 1.39
Transcatheter aortic valve implantation using direct aortic access: first procedures in Poland. Kardiol Pol (2012) 1.39
Age-related gap in the management of heart failure patients. The National Project of Prevention and Treatment of Cardiovascular Diseases--POLKARD. Cardiol J (2012) 1.39
Can thromboembolic risk be associated with erectile dysfunction in atrial fibrillation patients? Cardiol J (2015) 1.39
'Syringe-in-the-pocket'--a new approach to the outpatient thromboembolic prophylaxis of recurrent atrial fibrillation. Cardiology (2007) 1.39
Evaluation of safety and the success rate of cryoballoon ablation of the pulmonary vein ostia in patients with atrial fibrillation--a preliminary report. Kardiol Pol (2010) 1.39
Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis. Arch Intern Med (2005) 1.24
Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction. Eur J Heart Fail (2006) 1.22
Gender-specific mortality associated with alcohol consumption in Poland in transition. Addiction (2005) 1.19
Coexisting polymorphisms of P2Y12 and CYP2C19 genes as a risk factor for persistent platelet activation with clopidogrel. Circ J (2008) 1.16
Aortic dissection involving ostium of right coronary artery as the reason of myocardial infarction. Eur Heart J (2005) 1.15
[PM/ICD lead extraction - most difficult and potentially hazardous electrotherapy procedure - logistic and training problems]. Kardiol Pol (2010) 1.10
Letter by Cacko, et al Regarding Article, "Improvement of Cardiac Function by Increasing Stimulus Strength During Left Ventricular Pacing in Cardiac Resynchronization Therapy". Int Heart J (2015) 1.08
Clinical characteristics, aetiology and occurrence of type 2 acute myocardial infarction. Kardiol Pol (2013) 1.05
108th ENMC International Workshop, 3rd Workshop of the MYO-CLUSTER project: EUROMEN, 7th International Emery-Dreifuss Muscular Dystrophy (EDMD) Workshop, 13-15 September 2002, Naarden, The Netherlands. Neuromuscul Disord (2003) 1.04
Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland. Kardiol Pol (2007) 1.03
Tryptase levels in patients after acute coronary syndromes: the potential new marker of an unstable plaque? Clin Cardiol (2003) 1.02
Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty. Int J Cardiol (2006) 0.97
Altered gene expression pattern in peripheral blood mononuclear cells in patients with acute myocardial infarction. PLoS One (2012) 0.95
Baseline platelet size is increased in patients with acute coronary syndromes developing early stent thrombosis and predicts future residual platelet reactivity. A case-control study. Thromb Res (2009) 0.93
Association between variants on chromosome 4q25, 16q22 and 1q21 and atrial fibrillation in the Polish population. PLoS One (2011) 0.92
Purulent pericarditis in patient with esophageal cancer presenting with cardiac tamponade. J Emerg Med (2009) 0.91
Concomitant recovery of atrial mechanical and endocrine function after cardioversion in patients with persistent atrial fibrillation. J Am Coll Cardiol (2003) 0.89
Effect of ASA dose doubling versus switching to clopidogrel on plasma inflammatory markers concentration in patients with type 2 diabetes and high platelet reactivity: the AVOCADO study. Cardiol J (2013) 0.89
[POL-TAVI First--Polish report on transcatheter aortic valve implantation (TAVI) of Edwards-Sapien prosthesis in the first 19 high risk patients with severe aortic stenosis and comorbidities]. Kardiol Pol (2009) 0.88
Potency of pertussis component in the DTP vaccine--an overview of three decade study in Poland. Biologicals (2004) 0.88
Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study. Kardiol Pol (2003) 0.87
Hypertension as a predictive factor for survival outcomes in patients with metastatic renal cell carcinoma treated with sunitinib after progression on cytokines. Kidney Blood Press Res (2011) 0.87
Previously undiagnosed congenitally corrected transposition of the great arteries in a 51-year-old woman with chronic heart failure symptoms. Int J Cardiol (2006) 0.86
Images in cardiovascular medicine. Drug-induced long-QT syndrome with macroscopic T-wave alternans. Circulation (2004) 0.86
[Characteristics of bacteria isolated from body surface of German cockroaches caught in hospitals]. Przegl Epidemiol (2003) 0.86
Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes. Kardiol Pol (2013) 0.86
Can obstructive sleep apnea be a cause of in-stent thrombosis? Sleep Breath (2010) 0.86
[New model of the optimal oral antiplatelet treatment in patients with the ST-segment elevation myocardial infarction in Poland. Polish Cardiac Society statement]. Kardiol Pol (2011) 0.85
Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study. Int J Cardiol (2004) 0.85
The high risk of obstructive sleep apnea--an independent risk factor of erectile dysfunction in ST-segment elevation myocardial infarction patients. J Sex Med (2010) 0.85
The influence of left ventricle diastolic function on natriuretic peptides levels in patients with atrial fibrillation. Pacing Clin Electrophysiol (2009) 0.84
Factors responsible for "aspirin resistance" - can we identify them? Kardiol Pol (2010) 0.84
Clinical characteristics of patients with acute coronary syndrome at high clinical suspicion for obstructive sleep apnea syndrome. Hellenic J Cardiol (2013) 0.84
Influence of left atrial size on the outcome of pulmonary vein isolation in patients with atrial fibrillation. Kardiol Pol (2014) 0.83
The rs9982601 polymorphism of the region between the SLC5A3/MRPS6 and KCNE2 genes associated with a prevalence of myocardial infarction and subsequent long-term mortality. Pol Arch Med Wewn (2015) 0.83
Sunitinib malate, a receptor tyrosine kinase inhibitor, is effective in the treatment of restrictive heart failure due to heart metastases from renal cell carcinoma. Cardiology (2009) 0.83
Exercise urotensin II dynamics in myocardial infarction survivors with and without hypertension. Int J Cardiol (2005) 0.83
Assessment of CHADS2 and CHA 2DS 2-VASc scores in obstructive sleep apnea patients with atrial fibrillation. Sleep Breath (2014) 0.82
Younger age, higher body mass index and lower adiponectin concentration predict higher serum thromboxane B2 level in aspirin-treated patients with type 2 diabetes: an observational study. Cardiovasc Diabetol (2014) 0.82
Incidence, treatment, in-hospital mortality and one-year outcomes of acute myocardial infarction in Poland in 2009-2012--nationwide AMI-PL database. Kardiol Pol (2014) 0.82
Neuropsychological and neurological sequelae of out-of-hospital cardiac arrest and the estimated need for neurorehabilitation: a prospective pilot study. Kardiol Pol (2014) 0.82
Presence and severity of obstructive sleep apnea and remote outcomes of atrial fibrillation ablations - a long-term prospective, cross-sectional cohort study. Sleep Breath (2015) 0.81
Baseline platelet indices and bleeding after transcatheter aortic valve implantation. Blood Coagul Fibrinolysis (2015) 0.81